October 2011
Interview published on ecancer.tv with Dr. Pål Selbo at PCI Biotech AS - chosen as "editors pick"
Dr. Pål Selbo was interviewed in connection with the European Cancer Organization (ECCO) in Stockholm, September 24th. The interview was published on ecancer.tv and was rated as "editors pick" in the "Technologies" category.
September 2011
ODIN Therapeutics AS, a SFI-CAST spin-off company focusing on small molecular inhibitors of canonical Wnt signaling
ODIN Therapeutics AS recently announced the achievement of clinical candidate stage for its lead inhibitor of canonical Wnt signaling. “The success of ODIN Therapeutics AS shows that the concept of...
September 2011
SFI-CAST receives second term funding from the Research Council of Norway
SFI-CAST successfully passed the midterm evaluation by an international expert panel and receives full funding for its second term. "We are very pleased about the continued support...
May 2011
A new universal cancer vaccine for trial on humans 2012
A new universal cancer vaccine will be put on trial for testing on humans next year. The aim of the vaccine is to trigger the immune system to recognize the enzyme telomerase, which is over-produced by cancer cells and is responsible for ensuring that cancer cells can divide indefinitely (cell immortalization). Telomerase is an enzyme that is not expressed (shut off) in normal cells, thus only the cancer cells will be attacked, explains professor Gustav Gaudernack. Gaudernack, together with Anne-Marie Rasmussen and Else Marit Inderberg Suso, has been responsible for the research that led to the development of this vaccine.
February 2011
$ 25.000 Grant to CAST project
At the symposium for Mass Spectrometry 2011 Hafjell, Master student Hanne Roberg Larsen's presentation won the Waters Innovation Prize ($25.000 in instrumentation and services).
January 2011
- Vi kan hindre kreftspredning
Et gen slår ut kroppens egen spredningsbrems. Hvis vi kan blokkere dette genet, kan vi stoppe kreftspredning, hevder engelske forskere. - Interessant funn, mener norsk kreftforsker.
January 2011
På sporet av spredningsgåten
Ofte er spredning den avgjørende faktoren for en kreftsykdoms prognose. Norske forskere har funnet fram til en sentral faktor for spredningsprosessen.
November 2010
A Distinct Slow-Cycling Cancer Stem-like Subpopulation of Pancreatic Adenocarcinoma Cells is maintained in Vivo
November 2010
$250,000 Grant Awarded for Liposarcoma Research Study
At the annual meeting for Connective Tissue Oncology Society, recently held in Paris, it was announced that the American "Liddy Shriver Sarcoma Initiative" has donated a substantial sum to an ambitious international collaborative project. Here, Ola Myklebost's group at the Department of Tumor Biology at the Norwegian Radium Hospital is the only European partner. The project spans from basal biology to research on patients undergoing testing of novel treatment principles on the relatively rare cancer disease liposarcoma.
